As originally described, the Dick test was used to identify individuals with susceptibility to scarlet fever (8) . When broth culture filtrates from erythrogenic toxin-producing group A streptococci were injected intracutaneously into susceptible persons, erythematous and edematous skin reactions developed by 24 h after injection. Antitoxin neutralized the reactions (8) . Persons with sufficient circulating antitoxin did not develop positive skin responses, and they were therefore not considered susceptible to scarlet fever (8) .
Unlike the Dicks (8) , who thought the erythematous rash resulted from a direct (primary) toxic effect, others have emphasized the role of delayed hypersensitivity (secondary toxicity) in the reaction (3-5, 9, 13-15, 17, 18, 22) . The importance of age in developing scarlet fever (17) is consistent with the delayed-hypersensitivity concept. Scarlet fever is not observed in infants and becomes more prevalent only after repeated streptococcal infections. Rantz et al. (18) , after testing a large number of men of military age, determined that positive Dick tests were infrequent in men from geographical areas with low incidences of streptococcal infections.
These investigators concluded that the Dick reaction probably resulted from previous exposure, and therefore was the result of acquired hypersensitivity.
The work of Kim and Watson also implicated delayed hypersensitivity in development of skin reactivity (14, 15) . They proposed that group A streptococcal pyrogenic exotoxins (SPEs) contained primary toxic moieties which enhance hypersensitivity developed by the host to secondary toxic parts of the molecules. The primary toxicity has other effects on the host, including pyrogenicity (14, 20, 23) , enhancement of lethal shock and myocardial damage (14, 20, 21) , and alterations of the immune system (2, 6, 7, (10) (11) (12) , and this moiety of the molecules confers serological specificity. It was proposed also that the secondary toxic part may be shared by all three SPE types (15) .
This study was undertaken to elucidate the role of SPE in the development of the erythrogenic toxin rash, and therefore to define erythrogenic toxin more fully. Also, the SPEs were tested for a shared determinant which confers delayed hypersensitivity and which, once developed, can be enhanced by a primary toxicity. (19, 23) was used for production of partially purified (EtOH-2) and highly purified SPE C. The T18P strain does not produce SPEs A and B. Cultures were maintained in the lyophilized state in the presence of whole, defibrinated fresh rabbit blood.
Toxin preparation. SPEs were obtained from cellfree culture supernatant fluids of streptococci grown in a beef-heart dialysate medium (14, 23) . Toxins were purified using differential precipitation with -20'C ethanol and resolubilization in acetate-buffered saline, followed by preparative thin-layer isoelectric focusing (1, 14, 19, 23 Unlike nonsensitized rabbits, animals presensitized to the SPEs exhibited significant skin test reactions after challenge with homologous toxin ( Table 2 ). The skin reactions obtained were not typical delayed-hypersensitivity responses, but were intensely red with some edema. Representative examples of rabbits used in Tables 1 and  2 are shown in Fig. 1A and B. The animal shown in Fig. 1A was not sensitized, whereas that in Fig. 1B was presensitized to SPE C. Both animals were challenged with homologous toxin. Subsequent challenge of the same rabbits (from Table 2 ) 1 week later with homologous SPE resulted in typical delayed-hypersensitivity reactions in several of the animals ( Table 3 ). The reaction sites were edematous and yellow to orange in color. The overall reaction diameters decreased significantly compared to those presented in Table 2 . The level of significance for the differences between first (Table 2 ) and second (Table 3) challenges of sensitized animals is indicated in Table 3 . Together, the data presented in Tables 2 and 3 suggest that SPEs enhanced acquired skin reactivity to themselves, and that this enhanced reactivity was neutral- ized by antitoxin, which increased with repeated injection ofhomologous toxin until only delayedhypersensitivity reactions were expressed.
The SPEs were tested for capacity to enhance hypersensitivity reactions developed against unrelated proteins in rabbits. Animals presensitized to PPD showed significantly enhanced skin reactivity on one flank when challenged with PPD plus SPE C, compared to the other side, which received PPD alone ( b Average diameter after 24 h ± 1 standard error of the mean (SE).
P P values were determined using paired t-test analysis of data presented in Table 2 and this table. immune antiserum raised against SPE C effectively neutralized the enhanced skin reactivity to PPD (Table 4) ; typical delayed-hypersensitivity reactions to PPD remained. SPE C also enhanced Arthus reactions to an unrelated protein. Rabbits actively immunized against BSA showed greatly enhanced skin reactivity after challenge on one flank with BSA plus SPE C, compared to BSA alone on the opposite side (Table 5 ). After challenge with BSA alone, Arthus reactions were obtained with maximal edema occurring in approximately 8 h. The flanks receiving BSA plus SPE C, however, showed extensive edematous and erythematous skin reactions which persisted for at least 48 h and desquamated 5 to 10 days after injection. The reactions obtained after challenge with BSA plus SPE C most resembled scarlet fever rashes. The rabbit shown in Fig. 1C and D typifies the types of skin reactions obtained after challenge with BSA and BSA plus SPE C. The animal shown received BSA alone on one flank (Fig.  1C) and BSA plus SPE C on the other side (Fig.  iD) . A representative example of desquamation as a result of challenge with BSA plus SPE is shown in Fig. iF . Administration of antiserum to SPE C together with BSA plus SPE C resulted in neutralization of the enhanced reactivity (Table 5 ; Fig. lE) . Enhancement of passive local Arthus reactions by SPE C is shown in Table 6 . The reactions obtained, although significant, were not as pronounced as those from animals actively immunized to BSA and subsequently challenged. The data presented in Tables 4 to 6 demonstrate the potential of SPE to enhance both delayed and Arthus-type hypersensitivity reactions to unrelated antigens. Therefore, the erythrogenic toxin may represent SPE-enhanced skin reactivity to other antigens, or to the SPEs themselves, to which the host has acquired hypersensitivity.
The SPEs were then tested for capacity to enhance hypersensitivity reactions to other SPE types. By immunizing with one SPE type and then challenging with the others, it was possible to test for a common core part shared by all the SPEs, as proposed earlier (15) . All animals used in this study were challenged with homologous SPE until typical delayed-hypersensitivity skin reactions were obtained. EtOH-2 SPE C (200 ,ug/0.1 ml) was used in place of purified SPE C 15 ± 5.5 <0.001 Anti C a Rabbits were presensitized to BSA. b SE, Standard error of the mean. P P values were determined using paired t-test analysis of control and experimental reaction diameters.
d SPE C concentrations were 50 Mug/0.1 ml. Complex + SPE C 12 25 ± 1.4 (50Myg) aSE, Standard error of the mean. b P value was determined using paired t-test analysis of reaction diameters.
for skin testing to control for potential crossimmunization against trace ampholytes possibly carried along from toxin purifications. Rabbits sensitized to any of SPE types A, B, and C showed positive skin reactions when challenged with heterologous toxins (Table 7) , whether highly purified or EtOH-2. The reactions obtained, again, were typical ofenhanced skin reactivity rather than those of delayed hypersensitivity. The skin reactions were neutralized using antisera to the challenge toxin; typical delayedhypersensitivity reactions remained. The data indicate that the SPEs share a determinant to which delayed hypersensitivity could be developed. Once hypersensitivity was acquired, a serologically specific primary toxicity could enhance skin reactivity. DISCUSSION In this study the SPEs failed to produce skin test reactions upon primary injection into nonsensitized rabbits. The inability to invoke a skin reaction is consistent with research indicating that host-acquired hypersensitivity is required for development of the scarlet fever rash (3-5, 9, 13-15, 17, 18, 22) . The data suggest that primary toxicity alone, as proposed by the Dicks (8), is not responsible for rash development.
Investigators have equated SPEs with erythrogenic toxins (13, 16, 24) . In this paper the relationship of these two toxins was more fully studied; the SPEs significantly enhance acquired hypersensitivity reactions, both humoral and cell mediated, to either unrelated antigens or homologous or heterologous SPE. It is likely that the SPEs would enhance hypersensitivity reactions developed by the host to a variety of streptococcal products after repeated infections resulting in the erythrogenic toxin (scarlet fever) rash. The enhancement of hypersensitivity by SPEs is neutralized by specific antibody to the 1955) . The mechanism by which delayed-hypersensitivity skin reactions are enhanced may relate to the nonspecific lymphocyte mitogenicity of the SPEs (2). As proposed previously, the SPE molecules may consist of two parts, a primary toxicity and a secondary toxicity to which delayed hypersensitivity may be developed (15) . The host with delayed hypersensitivity to the secondary toxicity of SPEs or other antigens would be expected to show typical skin test reactivity when challenged with homologous antigen, resulting from lymphokine release by lymphocytes and recruitment of macrophages. An exaggeration of this effect may result when primary toxicity moieties are coadmninistered with antigen, stimulating release of more lymphokines and enhancing macrophage infiltration.
The enhancement of local Arthus reactions by SPEs appears more closely related to the typical scarlet fever rash. The greatly enhanced skin reaction with erythema may result from a more rapid and extensive infiltration of phagocytic cells and complement components. SPE C previously was shown to alter the permeability of the blood-brain barrier (20) and potentially could alter blood vessel permeability. Preliminary studies indicate that SPEs alter the permeability of vessels, as determined by Evans blue dye accumulation in tissues (unpublished data).
It is interesting that the SPE molecules appear to have two subparts, with the secondary toxic part being shared between SPE types, whereas the primary toxicity is serologically specific. Evidence for a shared determinant was provided previously, in which it was shown that VOL. 26, 1979 on October 27, 2017 by guest http://iai.asm.org/ 472 SCHLIEVERT, BETTIN, AND WATSON lymphocytes from guinea pigs sensitive to SPE A showed higher than expected responses to SPE B (2). It was proposed that the response represented a combination of nonspecific mitogenicity due to SPE B and specific cross-reactive mitogenicity induced by the shared determinant. The enhancement of skin reactivity to the shared determinant may be produced by any of the SPE types. Thus, the scarlet fever rash may be elicited during infection by a streptococcal strain producing any SPE type, after the host has been sensitized to the shared determinant or other streptococcal antigens and in the absence of circulating antibody to the serologically specific primary toxicity.
